FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991237567> ?p ?o ?g. }

• W1991237567 endingPage "39" @default.
• W1991237567 startingPage "33" @default.
• W1991237567 abstract "After discovery of insulin as a hypoglycemic agent in 1921 various routes of administration to control blood glucose were attempted. These included subcutaneous, oral, rectal, sublingual, buccal, transdermal, vaginal, intramuscular, intrapulmonary and intranasal delivery systems. While each delivery system controlled hyperglycemia the subcutaneous route was given priority until 2006 when the Federal Drug Administration (FDA) approved the first commercially available pulmonary inhaled insulin.A review of major publications dealing with intrapulmonary administration of insulin was made to understand the physiological basis for its use, its efficacy in controlling hyperglycemia, its side effects and a comparison of its efficacy with other delivery methods.The large surface area of the lung, its good vascularization, capacity for solute exchange and ultra thin membranes of alveolar epithelia are unique features that facilitate pulmonary insulin delivery. Large lung surface area ( approximately 75 m(2)) and thin alveolar epithelium ( approximately 0.1-0.5 microm) permit rapid drug absorption. First pass metabolism avoids gastrointestinal tract metabolism. Lung drug delivery depends upon a complex of factors including size, shape, density, charge and pH of delivery entity, velocity of entry, quality of aerosol deposition, character of alveoli, binding characteristics of aerosol on the alveolar surface, quality of alveolar capillary bed and its subsequent vascular tree. Many studies were performed to optimize each of these factors using several delivery systems to enhance pulmonary absorption. Availability was about 80% of subcutaneous administration with peak activity within 40-60 min of administration. Intranasal insulin delivery faces a smaller surface area ( approximately 180 cm(2)) with quite different absorption characteristics in nasal epithelium and its associated vasculature. Absorption depends upon many factors including composition and character of nasal mucus. Absorption of intranasal insulin resulted in a faster absorption time course than with subcutaneous insulin.After many studies the FDA approved Pfizer's product, Exubera, for intrapulmonary insulin delivery. While the system was effective its expense and putative side effects caused the drug company to withdraw the drug from the marketplace. Attempts by other pharmaceutical companies to use intrapulmonary insulin delivery are presently being made as well as some minor attempts to use intranasal delivery systems." @default.
• W1991237567 created "2016-06-24" @default.
• W1991237567 creator A5000578950 @default.
• W1991237567 date "2010-01-01" @default.
• W1991237567 modified "2023-10-03" @default.
• W1991237567 title "Inhaled insulin—Intrapulmonary, intranasal, and other routes of administration: Mechanisms of action" @default.
• W1991237567 cites W1238203966 @default.
• W1991237567 cites W1605452004 @default.
• W1991237567 cites W1914663845 @default.
• W1991237567 cites W1965007784 @default.
• W1991237567 cites W1965814735 @default.
• W1991237567 cites W1969266865 @default.
• W1991237567 cites W1970779072 @default.
• W1991237567 cites W1974323417 @default.
• W1991237567 cites W1981038717 @default.
• W1991237567 cites W1984423905 @default.
• W1991237567 cites W1987028155 @default.
• W1991237567 cites W1990481258 @default.
• W1991237567 cites W1991971027 @default.
• W1991237567 cites W2001338036 @default.
• W1991237567 cites W2006416887 @default.
• W1991237567 cites W2008449957 @default.
• W1991237567 cites W2014054345 @default.
• W1991237567 cites W2017488083 @default.
• W1991237567 cites W2018340655 @default.
• W1991237567 cites W2019861549 @default.
• W1991237567 cites W2027627351 @default.
• W1991237567 cites W2027742586 @default.
• W1991237567 cites W2028414858 @default.
• W1991237567 cites W2029666646 @default.
• W1991237567 cites W2031423995 @default.
• W1991237567 cites W2040414998 @default.
• W1991237567 cites W2040658994 @default.
• W1991237567 cites W2047173091 @default.
• W1991237567 cites W2049765266 @default.
• W1991237567 cites W2055226125 @default.
• W1991237567 cites W2067156066 @default.
• W1991237567 cites W2068028236 @default.
• W1991237567 cites W2076349473 @default.
• W1991237567 cites W2077756131 @default.
• W1991237567 cites W2083337622 @default.
• W1991237567 cites W2089660584 @default.
• W1991237567 cites W2091918414 @default.
• W1991237567 cites W2095919793 @default.
• W1991237567 cites W2109524144 @default.
• W1991237567 cites W2110995453 @default.
• W1991237567 cites W2123077376 @default.
• W1991237567 cites W2123541107 @default.
• W1991237567 cites W2127389807 @default.
• W1991237567 cites W2130417696 @default.
• W1991237567 cites W2133002147 @default.
• W1991237567 cites W2145133969 @default.
• W1991237567 cites W2152386842 @default.
• W1991237567 cites W2159889727 @default.
• W1991237567 cites W2159915554 @default.
• W1991237567 cites W2169304291 @default.
• W1991237567 cites W2171955365 @default.
• W1991237567 cites W2172244890 @default.
• W1991237567 cites W2386701702 @default.
• W1991237567 cites W4242295749 @default.
• W1991237567 cites W4243685637 @default.
• W1991237567 cites W4247473192 @default.
• W1991237567 cites W4252294132 @default.
• W1991237567 doi "https://doi.org/10.1016/j.nut.2009.08.001" @default.
• W1991237567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20005465" @default.
• W1991237567 hasPublicationYear "2010" @default.
• W1991237567 type Work @default.
• W1991237567 sameAs 1991237567 @default.
• W1991237567 citedByCount "47" @default.
• W1991237567 countsByYear W19912375672012 @default.
• W1991237567 countsByYear W19912375672013 @default.
• W1991237567 countsByYear W19912375672014 @default.
• W1991237567 countsByYear W19912375672015 @default.
• W1991237567 countsByYear W19912375672016 @default.
• W1991237567 countsByYear W19912375672017 @default.
• W1991237567 countsByYear W19912375672018 @default.
• W1991237567 countsByYear W19912375672019 @default.
• W1991237567 countsByYear W19912375672020 @default.
• W1991237567 countsByYear W19912375672021 @default.
• W1991237567 countsByYear W19912375672022 @default.
• W1991237567 countsByYear W19912375672023 @default.
• W1991237567 crossrefType "journal-article" @default.
• W1991237567 hasAuthorship W1991237567A5000578950 @default.
• W1991237567 hasConcept C126322002 @default.
• W1991237567 hasConcept C178790620 @default.
• W1991237567 hasConcept C185592680 @default.
• W1991237567 hasConcept C195735259 @default.
• W1991237567 hasConcept C205679159 @default.
• W1991237567 hasConcept C2776093070 @default.
• W1991237567 hasConcept C2777714996 @default.
• W1991237567 hasConcept C2779306644 @default.
• W1991237567 hasConcept C2779644171 @default.
• W1991237567 hasConcept C2779820397 @default.
• W1991237567 hasConcept C534529494 @default.
• W1991237567 hasConcept C71924100 @default.
• W1991237567 hasConcept C85663871 @default.
• W1991237567 hasConcept C98274493 @default.
• W1991237567 hasConceptScore W1991237567C126322002 @default.

• next